Stereotactic radiotherapy needs more evidence before it can be used routinely to treat metastases: A comment on the paper by Nicosia et al
- PMID: 35157977
- DOI: 10.1016/j.radonc.2022.02.005
Stereotactic radiotherapy needs more evidence before it can be used routinely to treat metastases: A comment on the paper by Nicosia et al
Keywords: Clinical trials; Colorectal cancer; Lung metastases; Stereotactic radiotherapy.
Comment in
-
Reply to: Stereotactic radiotherapy needs more evidence before it can be used routinely to treat metastases: A comment on the paper by Nicosia et al.Radiother Oncol. 2022 Apr;169:161-162. doi: 10.1016/j.radonc.2022.02.004. Epub 2022 Feb 11. Radiother Oncol. 2022. PMID: 35157979 No abstract available.
Comment on
-
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study.Radiother Oncol. 2022 Jan;166:92-99. doi: 10.1016/j.radonc.2021.10.023. Epub 2021 Nov 5. Radiother Oncol. 2022. PMID: 34748855
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
